BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32681351)

  • 1. EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition.
    Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
    Strahlenther Onkol; 2021 Feb; 197(2):141-149. PubMed ID: 32681351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.
    Zhen Q; Liu JF; Liu JB; Wang RF; Chu WW; Zhang YX; Tan GL; Zhao XJ; Lv BL
    Cancer Biol Ther; 2015; 16(4):549-57. PubMed ID: 25831463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
    Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M; Wang W; Ding J; Wang J; Zhang J
    Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
    Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
    Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
    Ma H; Liu B; Wang S; Liu J
    Cell Biochem Funct; 2016 Dec; 34(8):613-619. PubMed ID: 27862077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.
    Putra AC; Eguchi H; Lee KL; Yamane Y; Gustine E; Isobe T; Nishiyama M; Hiyama K; Poellinger L; Tanimoto K
    PLoS One; 2015; 10(8):e0134496. PubMed ID: 26263511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
    Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
    J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
    Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
    Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
    Xie M; He CS; Wei SH; Zhang L
    Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
    Chen Y; Yang S; Zhou H; Su D
    Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.
    Li X; Zhang Z; Jiang H; Li Q; Wang R; Pan H; Niu Y; Liu F; Gu H; Fan X; Gao J
    Cell Physiol Biochem; 2018; 51(5):2324-2340. PubMed ID: 30537738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3.
    Li C; Song G; Zhang S; Wang E; Cui Z
    Oncol Rep; 2015 Mar; 33(3):1207-14. PubMed ID: 25572698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.